Neurotheranostics Inc.
- UEI
- FWFNMKJWN2B9
- CAGE
- 7BRG5
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Website
- neurotheranostics.com
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Calpastatin peptide-based calpain inhibitor as a traumatic brain injury therapeutic | National Institute of Neurological Disorders and Stroke | $834,193 | |
| Sbir phase i tasking point of injury therapy to maintain and stabilize moderate-severe traumatic brain injury (TBI) | Medical Command | $146,079 |
Quick answers
What is Neurotheranostics Inc.'s UEI?
Neurotheranostics Inc.'s Unique Entity ID (UEI) in SAM.gov is FWFNMKJWN2B9.
What is Neurotheranostics Inc.'s CAGE code?
Neurotheranostics Inc.'s CAGE code is 7BRG5.
What is Neurotheranostics Inc.'s primary NAICS code?
Neurotheranostics Inc.'s primary NAICS code is 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)).
Is Neurotheranostics Inc. registered in SAM.gov?
Neurotheranostics Inc.'s SAM.gov registration expired on June 19, 2026.
What is Neurotheranostics Inc.'s most recent federal award?
Neurotheranostics Inc.'s most recent federal grant award is Calpastatin peptide-based calpain inhibitor as a traumatic brain injury therapeutic (R43NS107043), from National Institute of Neurological Disorders and Stroke, on September 1, 2019.
On GovTribe
See Neurotheranostics Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors